These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25082635)

  • 1. [Viscum album L. (Iscador) in the cat: tolerance, adverse reactions and indications].
    Glardon ; Pache ; Magnenat ; Pin ; Parvis
    Schweiz Arch Tierheilkd; 2014 Aug; 156(8):381-8. PubMed ID: 25082635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
    Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
    Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Course of mitogen-stimulated T lymphocytes in cancer patients treated with Viscum album extracts.
    Büssing A; Stumpf C; Tröger W; Schietzel M
    Anticancer Res; 2007; 27(4C):2903-10. PubMed ID: 17695469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disappearance of an advanced adenomatous colon polyp after intratumoural injection with Viscum album (European mistletoe) extract: a case report.
    von Schoen-Angerer T; Goyert A; Vagedes J; Kiene H; Merckens H; Kienle GS
    J Gastrointestin Liver Dis; 2014 Dec; 23(4):449-52. PubMed ID: 25532007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of metastatic malignant melanoma with Viscum album extract (Iscador M).
    Kirsch A
    J Altern Complement Med; 2007 May; 13(4):443-5. PubMed ID: 17532738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-related and adverse drug reactions to low versus high initial doses of Viscum album L. in cancer patients.
    Schad F; Thronicke A; Merkle A; Matthes H; Steele ML
    Phytomedicine; 2017 Dec; 36():54-58. PubMed ID: 29157828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune modulation using mistletoe (Viscum album L.) extracts Iscador.
    Büssing A
    Arzneimittelforschung; 2006 Jun; 56(6A):508-15. PubMed ID: 16927532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of higher dosages of Viscum album L. in animals and humans--systematic review of immune changes and safety parameters.
    Kienle GS; Grugel R; Kiene H
    BMC Complement Altern Med; 2011 Aug; 11():72. PubMed ID: 21871125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador.
    Urech K; Schaller G; Jäggy C
    Arzneimittelforschung; 2006 Jun; 56(6A):428-34. PubMed ID: 16927522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory and clinical effects of Viscum album (Iscador M and Iscador P) in children with recurrent respiratory infections as a result of the Chernobyl nuclear accident.
    Chernyshov VP; Heusser P; Omelchenko LI; Chernyshova LI; Vodyanik MA; Vykhovanets EV; Galazyuk LV; Pochinok TV; Gaiday NV; Gumenyuk ME; Zelinsky GM; Schaefermeyer H; Schaefermeyer G
    Am J Ther; 2000 May; 7(3):195-203. PubMed ID: 11317168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
    Grossarth-Maticek R; Ziegler R
    Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.
    Gardin NE
    Phytother Res; 2009 Mar; 23(3):407-11. PubMed ID: 19003944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Dose Viscum album Extract Treatment in the Prevention of Recurrent Bladder Cancer: A Retrospective Case Series.
    von Schoen-Angerer T; Wilkens J; Kienle GS; Kiene H; Vagedes J
    Perm J; 2015; 19(4):76-83. PubMed ID: 26517439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory effects of Viscum album extracts on natural killer cells: review of clinical trials.
    Braedel-Ruoff S
    Forsch Komplementmed; 2010 Apr; 17(2):63-73. PubMed ID: 20484913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of Combined Treatment With Monoclonal Antibodies and Viscum album L Preparations.
    Schad F; Axtner J; Kröz M; Matthes H; Steele ML
    Integr Cancer Ther; 2018 Mar; 17(1):41-51. PubMed ID: 29444603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunostimulatory properties of mistletoe extracts and their application in oncology].
    Wrotek S; Skawiński R; Kozak W
    Postepy Hig Med Dosw (Online); 2014 Oct; 68():1216-24. PubMed ID: 25380204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local reactions to treatments with Viscum album L. extracts and their association with T-lymphocyte subsets and quality of life.
    Büssing A; Tröger W; Stumpf C; Schietzel M
    Anticancer Res; 2008; 28(3B):1893-7. PubMed ID: 18630477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytochemical analysis and in vitro anti-proliferative activity of Viscum album ethanolic extracts.
    Holandino C; Melo MNO; Oliveira AP; Batista JVDC; Capella MAM; Garrett R; Grazi M; Ramm H; Torre CD; Schaller G; Urech K; Weissenstein U; Baumgartner S
    BMC Complement Med Ther; 2020 Jul; 20(1):215. PubMed ID: 32646417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro.
    Weissenstein U; Kunz M; Urech K; Regueiro U; Baumgartner S
    BMC Complement Altern Med; 2016 Aug; 16():271. PubMed ID: 27491866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo.
    Cebović T; Spasić S; Popović M
    Phytother Res; 2008 Aug; 22(8):1097-103. PubMed ID: 18570233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.